NASDAQ:RDNT
RadNet Stock News
$58.23
-0.260 (-0.445%)
At Close: May 21, 2024
Did This Company Just Win Big Because of Biogen?
05:33am, Sunday, 20'th Jun 2021
Alzheimer's disease patients who take Aduhelm will need a lot of diagnostic scans, too. Imaging leader RadNet stands to benefit.
RadNet (RDNT) Soars 10%: Is Further Upside Left in the Stock?
11:17pm, Wednesday, 09'th Jun 2021
RadNet (RDNT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t
RadNet, Inc. to Present at the Jefferies 2021 Virtual Healthcare Conference on June 3, 2021
06:00am, Wednesday, 26'th May 2021
LOS ANGELES, May 26, 2021 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and
RadNet, Inc. (RDNT) CEO Howard Berger on Q1 2021 Results - Earnings Call Transcript
02:03pm, Monday, 10'th May 2021
RadNet, Inc. (RDNT) CEO Howard Berger on Q1 2021 Results - Earnings Call Transcript
RadNet (RDNT) Q1 Earnings and Revenues Beat Estimates
08:16am, Monday, 10'th May 2021
RadNet (RDNT) delivered earnings and revenue surprises of 180.00% and 7.05%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
RadNet: Q1 Earnings Insights
07:09am, Monday, 10'th May 2021
Shares of RadNet (NASDAQ:RDNT) were unchanged after the company reported Q1 results. Quarterly Results Earnings per share increased 112.12% year over year to $0.04, which beat the estimate of ($0.03).
RadNet (RDNT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
03:47pm, Monday, 03'rd May 2021
RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Shields Health Care Group Deploys eRAD RIS to Streamline Efficiency Across Enterprise
06:00am, Monday, 03'rd May 2021
GREENVILLE, S.C., May 3, 2021 /PRNewswire/ -- eRAD, a subsidiary of RadNet, Inc. (NASDAQ: RDNT), a leading provider of RIS (Radiology Information System) and PACS (Picture Archiving and Communication
RadNet Announces the Closing of Its Previously Announced Refinancing Transaction
06:00am, Monday, 26'th Apr 2021
LOS ANGELES, April 26, 2021 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and/or
RadNet (RDNT) Upgraded to Buy: Here's Why
01:09pm, Monday, 19'th Apr 2021
RadNet (RDNT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
RadNet's Artificial Intelligence Subsidiary, DeepHealth, Announces FDA Clearance for its AI Mammography Triage Software
06:00am, Monday, 19'th Apr 2021
CAMBRIDGE, Mass. and LOS ANGELES, April 19, 2021 (GLOBE NEWSWIRE) -- RadNet, Inc., (NASDAQ: RDNT) today announced that its subsidiary DeepHealth, a leading developer of artificial intelligence (AI) fo
LOS ANGELES, April 06, 2021 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and/or o
RadNet, Inc. to Present at the Sidoti & Company Spring 2021 Virtual Investor Conference on Wednesday, March 24th
06:00am, Wednesday, 17'th Mar 2021
LOS ANGELES, March 17, 2021 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned an
RadNet, Inc. (RDNT) CEO Howard Berger on Q4 2020 Results - Earnings Call Transcript
04:39pm, Monday, 08'th Mar 2021
RadNet, Inc. (RDNT) CEO Howard Berger on Q4 2020 Results - Earnings Call Transcript
RadNet (RDNT) Q4 Earnings and Revenues Top Estimates
08:21am, Monday, 08'th Mar 2021
RadNet (RDNT) delivered earnings and revenue surprises of 25.00% and 1.82%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?